Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinoma

Molecular Medicine Reports

Volumn 6, Issue 1, 2012, Pages 163-166

  De Oliveira, Marília Gerhardt ^a   Pereira Ramalho, Luciana Maria ^b   Gaião, Leonilson ^c   Pozza, Daniel Humberto ^d   De Mello, Ramon Andrade ^d  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Biomarkers; Leukoplakia; Mouth mucosa; Mouth neoplasm; p53; Retinoblastoma; Squamous cell carcinoma

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; BIOPSY; CARCINOGENESIS; CELL CYCLE REGULATION; CHEILITIS; COMPARATIVE STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH LESION; MOUTH SQUAMOUS CELL CARCINOMA; PRECANCER; PROTEIN EXPRESSION; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEILITIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM GRADING; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84861597649     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.876     Document Type: Article

References (23)

1. Jemal A, Bray F, Center M, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
3. de Mello R, Costa B, Reis R and Hespanhol V: Insights into angiogenesis in non-small cell lung cancer: molecular mechanisms, polymorphic genes, and targeted therapies. Recent Pat Anticancer Drug Discov 7: 118-131, 2012.
4. de Mello R, Figueiredo P, Marques M, Sousa G, Carvalho T and Gervásio H: Concurrent breast stroma sarcoma and breast carcinoma: a case report. J Med Case Reports 4: 414, 2010.
5. Osman I, Sherman E, Singh B, et al: Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. J Clin Oncol 20: 2980-2987, 2002. (Pubitemid 34728893)
6. Mojtahedi Z, Hashemi S, Khademi B, et al: p53 codon 72 polymorphism association with head and neck squamous cell carcinoma. Braz J Otorhinolaryngol 76: 316-320, 2010.
7. Sartor M, Steingrimsdottir H, Elamin F, et al: Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Br J Cancer 80: 79-86, 1999. (Pubitemid 29210092)
8. Tanaka N, Ogi K, Odajima T, et al: pRb2/p130 protein expression is correlated with clinicopathologic findings in patients with oral squamous cell carcinoma. Cancer 92: 2117-2125, 2001. (Pubitemid 32973322)
9. Bryne M, Koppang H, Lilleng R and Kjaerheim A: Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166: 375-381, 1992.
10. Machiels J and Schmitz S: Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck. Expert Rev Anticancer Ther 11: 359-371, 2011.
11. Massano J, Regateiro F, Januário G and Ferreira A: Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102: 67-76, 2006. (Pubitemid 44016111)
12. Ko C and Citrin D: Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck. Oral Dis 15: 121-132, 2009.
13. Reed E: Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treat Rev 24: 331-344, 1998.
14. Grem J: 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Invest New Drugs 18: 299-313, 2000.
15. Feller L, Wood N, Khammissa R and Lemmer J: Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 1: human papillomavirus-mediated carcinogenesis. Head Face Med 15: 14, 2010.
16. Partridge M, Emilion G, Pateromichelakis S, A'Hern R, Phillips E and Langdon J: Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer. Oral Oncol 34: 77-83, 1998. (Pubitemid 28207005)
17. Nakahara Y, Shintani S, Mihara M, Kiyota A, Ueyama Y and Matsumura T: Alterations of Rb, p16(INK4A) and cyclin D1 in the tumorigenesis of oral squamous cell carcinomas. Cancer Lett 160: 3-8, 2000.
18. Sudbø J and Reith A: Which putatively pre-malignant oral lesions become oral cancers? Clinical relevance of early targeting of high-risk individuals. J Oral Pathol Med 32: 63-70, 2003. (Pubitemid 36604031)
19. Girod S, Pfeiffer P, Ries J and Pape H: Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg 36: 252-260, 1998.
20. de Oliveira L, Ribeiro-Silva A and Zucoloto S: Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J Oral Pathol Med 36: 191-197, 2007.
21. Shah N, Trivedi T, Tankshali R, et al: Prognostic significance of molecular markers in oral squamous cell carcinoma: a multi-variate analysis. Head Neck 31: 1544-1556, 2009.
22. Weinberger P, Merkley M, Lee J, et al: Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites. Arch Otolaryngol Head Neck Surg 135: 694-703, 2009.
23. Brunotto M, Zárate A, Cismondi A, Fernández Mdel C and Noher de Halac R: Valuation of exfoliative cytology as prediction factor in oral mucosa lesions. Med Oral Patol Oral Cir Bucal 10: E92-E102, 2005.